Sight Sciences, Inc. (SGHT)
8.89
+0.42
(+4.96%)
USD |
NASDAQ |
Oct 09, 16:00
8.89
0.00 (0.00%)
After-Hours: 20:00
Sight Sciences Cash from Investing (Quarterly) : -0.019M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.019M |
| March 31, 2026 | -0.06M |
| December 31, 2025 | 0.156M |
| September 30, 2025 | -0.17M |
| June 30, 2025 | -0.21M |
| March 31, 2025 | 0.00 |
| December 31, 2024 | -0.137M |
| September 30, 2024 | -0.051M |
| June 30, 2024 | -0.08M |
| March 31, 2024 | -0.117M |
| December 31, 2023 | -0.264M |
| September 30, 2023 | -0.304M |
| June 30, 2023 | -0.097M |
| Date | Value |
|---|---|
| March 31, 2023 | -0.126M |
| December 31, 2022 | -0.129M |
| September 30, 2022 | -0.272M |
| June 30, 2022 | -0.342M |
| March 31, 2022 | -0.227M |
| December 31, 2021 | -0.157M |
| September 30, 2021 | -0.287M |
| June 30, 2021 | -0.265M |
| March 31, 2021 | -0.104M |
| December 31, 2020 | -0.302M |
| September 30, 2020 | -0.119M |
| June 30, 2020 | -0.019M |
| March 31, 2020 | -0.513M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | -43.28M |
| Abbott Laboratories | -673.00M |
| AngioDynamics, Inc. | -3.148M |
| Alphatec Holdings, Inc. | -22.72M |
| AtriCure, Inc. | -3.766M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.663M |
| Cash from Financing (Quarterly) | 0.474M |
| Free Cash Flow | -23.33M |
| Free Cash Flow Per Share (Quarterly) | -0.1042 |
| Free Cash Flow to Equity (Quarterly) | -6.765M |
| Free Cash Flow to Firm (Quarterly) | -4.384M |
| Free Cash Flow Yield | -4.91% |